585 related items for PubMed ID: 12063520
1. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
2. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
3. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
4. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
[Abstract] [Full Text] [Related]
5. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED, Silins V, Bogolubov M.
Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
[Abstract] [Full Text] [Related]
6. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
7. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
8. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
9. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ, Stampone P, O'Connor BJ.
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[Abstract] [Full Text] [Related]
10. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[Abstract] [Full Text] [Related]
11. Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.
Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P.
J Asthma; 2004 Jun; 41(8):797-806. PubMed ID: 15641629
[Abstract] [Full Text] [Related]
12. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
J Int Med Res; 2007 Jun; 35(3):361-73. PubMed ID: 17593865
[Abstract] [Full Text] [Related]
13. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
[Abstract] [Full Text] [Related]
14. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD.
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
[Abstract] [Full Text] [Related]
15. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
Currie GP, Stenback S, Lipworth BJ.
Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
[Abstract] [Full Text] [Related]
16. Clinical evaluation of CFC-free metered dose inhalers.
Jenkins M.
J Aerosol Med; 1995 Jul; 8 Suppl 1():S41-7. PubMed ID: 10150495
[Abstract] [Full Text] [Related]
17. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
18. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[Abstract] [Full Text] [Related]
19. Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.
Currie GP, Bates CE, Lee DK, Jackson CM, Lipworth BJ.
Eur J Clin Pharmacol; 2003 May; 59(1):11-5. PubMed ID: 12743669
[Abstract] [Full Text] [Related]
20. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T, Silkoff PE, Kossack WS, Nelson HS.
J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
